Spatial scene memory testing for people with temporal lobe epilepsy having surgery

Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery

Not applicable Interventional University of California, Davis · NCT07580183

This project tests whether a virtual tour memory task combined with brain recordings can show how adults with temporal lobe epilepsy recognize and recall places.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment620 (estimated)
Ages18 Years to 55 Years
SexAll
SponsorUniversity of California, Davis Academic / other
Locations2 sites (Sacramento, California and 1 other locations)
Trial IDNCT07580183 on ClinicalTrials.gov

What this trial studies

The study separates familiarity-based recognition from recollection using a validated virtual tour task and combines three complementary approaches. At Emory, voxel-based lesion-symptom mapping will be performed in a large cohort of surgical patients (~310) with additional controls (~150) alongside MRI and neuropsychological testing. At UC Davis, scalp event-related potentials and eye tracking will be recorded in about 80 healthy adults to characterize temporal dynamics and lateralization. In patients undergoing stereoelectroencephalography (~80), intracranial LFP and single-unit recordings using research micro-macro electrodes will capture neural activity related to scene recognition.

Who should consider this trial

Good fit: Ideal candidates are adults (≥18) with focal or temporal lobe epilepsy undergoing evaluation or surgery (IQ ≥ 70, English proficient) and, for the healthy control arm, age-eligible adults without neurological or psychiatric disorder.

Not a fit: People under 18, those with IQ below 70, non-English speakers, patients not treated at the participating centers, and those over 55 (for the intracranial component) are unlikely to receive direct benefit from participation.

Why it matters

Potential benefit: If successful, the work could produce tools to better predict and preserve memory after epilepsy surgery and improve counseling and surgical planning.

How similar studies have performed: Prior lesion-mapping, scalp ERP, eye-tracking, and intracranial recording studies have advanced understanding of memory, but combining large-scale lesion mapping with multi-site intracranial single-unit recordings is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* For Aims I and III: Diagnosis of focal epilepsy or temporal lobe lesion; patients undergoing evaluation for or having undergone epilepsy surgery
* For Aim II: Healthy adult participants
* Full-Scale IQ ≥ 70
* English proficiency sufficient to understand and complete the task
* For Aim I: Enrolled in or eligible for Emory University epilepsy surgery research registry
* For Aim III: Undergoing clinically indicated stereoelectroencephalography (SEEG) at UC Davis Medical Center
* Able to provide informed consent (or for Aim I retrospective component, prior consent in Emory registry)

Exclusion Criteria:

* Full-Scale IQ \< 70
* Inability to provide informed consent
* For Aim III: Age \> 55 years
* For Aim II: History of neurological or psychiatric disorder (as applicable per study protocol)

Where this trial is running

Sacramento, California and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Focal EpilepsyTemporal Lobe EpilepsyMedically Refractory EpilepsyMemory DisordersEpilepsy ComorbiditiesEpilepsy IntractableEpilepsy SurgeryEpilepsy, Temporal Lobe
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.